This inventor holds 2 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 1997-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Linding o, SE (1997)
- Lidingö, SE (2001)
Company Filing History:
Years Active: 1997-2001
Title: Suad Efendic: Innovator in Diabetes Treatment
Introduction
Suad Efendic is a notable inventor based in Lindingo, Sweden. He has made significant contributions to the field of diabetes treatment through his innovative research and development. With a total of 2 patents, Efendic is recognized for his work in peptide-based therapies.
Latest Patents
One of Suad Efendic's latest patents involves the use of GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus. This invention aims to enhance the effectiveness of diabetes management and improve patient outcomes.
Career Highlights
Efendic is currently associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to focus on developing innovative solutions for diabetes treatment, contributing to the company's mission of improving the lives of people with diabetes.
Collaborations
Throughout his career, Suad Efendic has collaborated with esteemed colleagues, including Ole Kirk and Mark Gutniak. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Suad Efendic's contributions to diabetes treatment through his patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the lives of many individuals living with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile